In closing, we are focused on bringing increased discipline and rigor to our revenue forecasting and expense management processes. Though we are not satisfied with our results, we are confident in our ability to drive revenue growth and expand our margins as we deliver our balance sheet and prepare for future milestone payments related to CAR to HEAL.

Nov 8, 2022 / receipt, needs a key / Mark Singleton, CFO | earnings call 2022-11-08 | transcript d5fd1b0e-2988-4ac2-a38c-daf64ba686a6 | chars 21595-21948 | segment 21

Higher sales volume was offset by higher operating costs related to our acquisition of Masonics and a return to more normal travel cadence for our sales teams.

May 10, 2022 / receipt, needs a key / CEO, CEO | earnings call 2022-05-10 | transcript 58a8f1f0-8125-400e-b3f9-b58febf8c2c9 | chars 14888-15047 | segment 15

The increase in operating expense compared to the prior year period was primarily driven by investments in our selling and marketing organization, public company costs, which did not impact the prior year period results, and the resumption of discretionary spending, including travel and related expenses given the more normalized business environment as compared to the significant cost reduction efforts in the prior year period as a result of the COVID-19 pandemic, as well as operating expenses related to our acquisition of Bioness, which did not impact the prior year period.

Aug 10, 2021 / receipt, needs a key / Greg Englund, CFO | earnings call 2021-08-10 | transcript 52fe2725-7a06-4648-a3d6-cdd54195d6c2 | chars 18262-18843 | segment 18